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Abstract
Background and Aims Gastroesophageal reflux disease (GERD) is a spectrum of disease that includes nonerosive reflux disease
(NERD), erosive reflux disease (ERD), and Barrett’s esophagus (BE). Treatment outcomes for patients with different stages have
differed in many studies. In particular, acid suppressant medication therapy is reported to be less effective for treating patients
with NERD and Barrett’s esophagus. The aims of this study were to investigate (1) the role of mechanical factors including hiatal
hernia and lower esophageal sphincter (LES) competence in the spectrum of GERD and (2) outcomes of Nissen fundoplication.
Methods From the records of patients who had undergone laparoscopic Nissen fundoplication after an abnormal pH study, we
identified 50 symptomatic consecutive patients with each of the GERD stages: (1) NERD, (2) mild ERD, defined as esophagitis
that was healed with acid suppression therapy, (3) severe ERD, defined as esophagitis that persisted despite medical therapy, and
(4) BE. Exclusion criteria were normal distal esophageal acid exposure, esophageal pH monitoring performed elsewhere,
antireflux surgery less than 1 year previously or previous fundoplication, and a named esophageal motility disorder or distal
esophageal low amplitude hypomotility. Patients who could not be contacted for the study were also excluded. All patients
completed a detailed preoperative questionnaire; underwent preoperative upper gastrointestinal endoscopy, stationary
manometry, and distal esophageal pH monitoring; and were interviewed at least 1 year after operation.
Results One hundred sixty patients meeting the entry criteria were studied. The mean follow-up period was 36.7 months.
The only significant preoperative symptom difference was that patients with BE had more moderately severe or severe
dysphagia compared to patients with NERD. Patients with severe ERD or BE had a significantly higher prevalence of hiatal
hernia, lower LES pressures, and more esophageal acid exposure. Hiatal hernia and hypotensive LES were present in most
patients with severe ERD or BE but in only a minority of patients with NERD or mild ERD. Surgical therapy resulted in
similarly excellent symptom outcomes for patients in all GERD categories.
Conclusions Compared to mild ERD and NERD, severe ERD and BE are associated with significantly greater loss of the
mechanical antireflux barrier as reflected in the presence of hiatal hernia and LES measurements. Restoration of the antireflux
barrier and hernia reduction by laparoscopic Nissen fundoplication provides similarly excellent symptom control in all patients.
Keywords Gastroesophageal reflux disease . Barrett’s
esophagus . Nonerosive reflux disease . Nissen
fundoplication . Antireflux surgery
Introduction
Gastroesophageal reflux disease (GERD) is a spectrum of
disease that extends from nonerosive reflux disease (NERD),
in which there are nomucosal breaks on endoscopy, to erosive
esophagitis or to Barrett’s esophagus (BE).1 It is currently
estimated that between 50% and 70% of patients with GERD
have NERD,2–4 5% to 10% have BE, and the remainder have
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erosive reflux disease (ERD), with either esophageal
erosions or ulcerations.5 As a group, patients with NERD
have symptom and quality of life scores similar to patients
with erosive reflux disease (ERD).4,6 Patients can progress
from NERD to ERD, even on proton-pump inhibitor (PPI)
therapy, but progression from ERD to BE is uncommon and
from NERD to BE is very uncommon.7–9 Labenz et al.
reported on the progression of GERD (ProGERD) study of
3,894 patients with GERD who underwent baseline endos-
copy and repeat endoscopy at 2 years.8 As is characteristic of
a disease spectrum, many patients had progressed or
regressed from one GERD stage to another. Approximately
one quarter of patients with NERD had progressed to mild
ERD and most patients with ERD had regressed to NERD
(treatment was allowed). Patients with severe ERD had the
highest rate (5.8%) of progression to BE.8
Numerous studies have shown that patients with ERD or
BE are effectively treated by antireflux surgery, with safe,
long-term control of reflux symptoms, normalization of
esophageal acid and nonacid exposure, and a significant
improvement in quality of life.10–14 Few data, in contrast,
are available on the results of surgical therapy for all stages
of the GERD spectrum including NERD.13,15 The results of
surgical treatment are especially important for patients with
NERD as medical treatments are widely reported as being
less effective for these patients.16–18 In this study, we
investigated the influence of the endoscopically defined
GERD stage on the outcome of laparoscopic Nissen
fundoplication. We also compared the demographic,
clinical, and physiologic features of patients with different
stages of GERD. In particular, we studied the importance
of hiatal hernia and lower esophageal sphincter compe-
tence, factors which have received less emphasis in other
studies.
Patients and Methods
The clinical and esophageal physiology records of patients
who had been treated by laparoscopic Nissen fundoplication
at the University of Southern California Keck School of
Medicine Department of Foregut Surgery (USC) were
reviewed. All patients had symptoms suggestive of reflux
disease. The mucosal appearance at preoperative endoscopies
was used to identify 50 consecutive patients with NERD, 50
consecutive patients with mild ERD, 50 consecutive patients
with severe ERD, and 50 consecutive patients with BE. The
sample size of 50 patients was selected after a preliminary
review of our database indicated that this was likely the
maximum number of patients with NERD and persistent
esophagitis (severe ERD) available for inclusion in the study
period. Since the statistical power of a study is increased by
only a relatively small and inefficient amount when the sample
sizes are unequal, we did not include all available patients but
aimed to limit the sample size to 50 patients in each group.
Patients were classified as having NERD if they had no
record of esophagitis, with esophagitis defined by the
presence of erosions or ulcerations (modified Savary Miller
classification19) at any endoscopy. Patients who had
received acid suppressant medication therapy prior to their
initial endoscopy were excluded from this group. The acid
suppressant medication history prior to endoscopy at USC
was obtained from the referral letters, USC surgeon’s files
and reports, and from the patients.
Patients with no erosive esophagitis at preoperative
endoscopy but a history of ERD at a previous endoscopy that
had been healed by acid suppressant drug therapy were
classified as having mild (or healed) ERD. Severe ERD was
defined as persistent or nonhealed esophagitis and was
diagnosed when esophagitis was found at the preoperative
endoscopy in patients who had received at least some acid
suppressant therapy. This included PPI therapy in all cases but
we did not include the type or dose of medication received as a
factor or perform a subanalysis of the medical therapy asmany
larger studies have addressed the effectiveness of acid
suppressive medication using more robust methods including
many randomized controlled trials. All patients with ERD thus
had at least two endoscopies. BE was diagnosed by the
presence of microscopic intestinal metaplasia in a macroscop-
ic columnar-lined esophagus of any length.
All patients underwent preoperative endoscopy per-
formed by the authors at this institution. The results of
endoscopies performed elsewhere were obtained from the
medical history and the documents and letters of the
referring physician. In order to ensure that only patients
with definite GERD were studied, only patients with
abnormal distal esophageal acid exposure were included.
Patients were excluded if they had undergone Nissen
fundoplication less than 1 year previously, if they had had
more than one previous antireflux operation, or if they could
not be contacted for this study. Patients who had not had a
preoperative ambulatory pH study at this institution were also
excluded, as were those with a named esophageal motility
disorder or distal esophageal low amplitude hypomotility,
defined as a mean contraction amplitude less than 20 mmHg.
A hiatal hernia was diagnosed when the gastroesophageal
junction was located 2 cm or more proximal to the crural
impression at endoscopy, with the gastroesophageal junction
defined as the proximal extent of the gastric rugal folds.
Symptom Assessment
All patients completed a structured symptom questionnaire
at the time of their esophageal pH examination. The
symptom of heartburn was graded as 0 (none), 1 (mild;
occasional episodes), 2 (moderate; primary reason for
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medical visit), or 3 (severe; effects daily life). Regurgitation
was graded as 0 (none), 1 (mild; occasional episode after
straining or large meal), 2 (moderate, predictable with
position change or straining), or 3 (severe, effects daily life,
possibly with a history of aspiration). Dysphagia was
graded as 0 (none), 1 (mild; occasionally with coarse
foods; lasting a few seconds), 2 (moderate; requiring
clearing with liquids), or 3 (severe; requiring a semiliquid
diet and with a history of meat impaction). These
descriptors were also used for postoperative symptom
assessment. In order to limit the number of statistical
comparisons and the consequent risk of false positive
findings, the symptom findings were classified as either
“none or mild” or “moderate or severe”.
Manometry
All patients underwent preoperative manometry testing.
Stationary motility was performed after an overnight fast
using a single catheter assembly consisting of five
polyethylene tubes bonded together with five lateral open-
ings placed at 5-cm intervals from the distal end and
oriented radially around the circumference. Using a
pneumohydraulic low compliance pump (Arndorfer Medi-
cal Specialties, Greendale, WI, USA), the catheter was
perfused with distilled water at a constant rate of
0.6 mL/min. A stationary pull through of the lower
esophageal sphincter (LES) and a manual analysis of the
polygraph recordings were performed. LES resting pressure
was measured at the respiratory inversion point, as
described previously.20 The resting pressure, overall length,
and abdominal length of the LES were calculated from the
mean of the five recordings. A structurally defective LES
was defined either by a resting pressure <6 mmHg, overall
length <2 cm, abdominal length <1 cm, or any combination
of these. Assessment of the esophageal body motility was
performed as described previously.20
pH and Bilirubin Monitoring
All the patients underwent 24-h distal esophageal pH
monitoring. Proton-pump inhibitor medications were dis-
continued at least 2 weeks before testing and other reflux
medications were discontinued at least 72 h before testing.
The pH monitoring was performed as previously described,
by positioning a glass pH electrode (Mui Scientific, Toronto,
Ontario, Canada) or an antimony crystal ph electrode
(Synectics Medical, Irving, TX, USA) 5 cm above the
manometrically measured upper border of the LES.21 The
electrode was connected to a digital recording device
(Microdigitrapper, Synectics Medical, Irving, TX, USA)
and pH continually monitored for 24 h. The patients’ diets
were limited to foods having a pH in the range 5–7. The
stored data were transferred to a personal computer and
analyzed using a standard software package (Multigram,
Gastrosoft, Irving, TX, USA). All patients had abnormal
esophageal acid exposure, with an esophageal pH less than 4
for more than 4.4% of the total study period.21
Esophageal exposure to duodenal juice was measured
using a fiberoptic probe designed to detect bilirubin by
spectrophotometry at 453 nm, the specific wavelength for
absorption of bilirubin (Bilitec 2000, Medtronic Synectics,
Shoreview, MN, USA).22 The probe was passed trans-
nasally and positioned at the same level as the pH
electrode. Twenty-four-hour absorbance data were
recorded on a portable optoelectric data logger and
analyzed with a software program (Multigram, Gastrosoft,
Irving, TX, USA). Bilirubin exposure was quantified as
the percentage of time above an absorbance threshold of
0.2. The upper limit of the normal range for bilirubin
exposure was 1.7% of the total time above an absorbance
threshold of 0.2.22 Patient diets were restricted to three
meals per day with no foods with an absorbance similar to
that of bilirubin.
Operative Technique
Laparoscopic Nissen fundoplication was performed as
previously described.23 Important technical elements in-
cluded crural and hiatal dissection, crural closure, and
complete fundic mobilization by division of the short
gastric vessels. A 2-cm loose fundoplication was con-
structed over a 60-Fr bougie by enveloping the distal
esophagus with the anterior and posterior walls of the
gastric fundus so that the anterior and posterior fundic lips
met at the right lateral position on the esophagus.
Statistical Analysis
Fisher’s exact test was used to compare proportions
between two groups and the linear-by-linear chi-square test
was used to compare proportions between more than two
groups. Continuous data were compared using the Mann–
Whitney U test for two groups and the Kruskal–Wallis test
for more than two groups. All P values are two-sided. SPSS
version 10.0.5 software (SPSS Inc., Chicago IL, USA) was
used for all statistical analyses. All values are shown as
median with (interquartile range) or as number of patients
with (percentage).
Results
After excluding patients according to the criteria listed above,
the study population consisted of 160 patients. The number
of patients in each GERD category and demographic data are
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shown in Table 1. There were no significant differences
between the patients in the four GERD categories for either
age (P value for all groups 0.86, chi-square test) or sex (P
value for all groups 0.19, chi-square test). There were also
no significant differences between any two individual groups
for these factors. The mean follow-up period was
36.7 months for all 160 patients (median 30 months, range
12–92 months). The duration of follow-up was significantly
longer for BE patients compared to patients in any of the
other groups but was not significantly different between any
of the other three patient groups (Table 1 legend).
Preoperative Evaluation
Symptoms
Preoperative symptom results are shown in Table 2. The only
significant differences were that a higher proportion of
patients with severe ERD had moderately severe or severe
regurgitation compared to patients with mild ERD (P=0.05),
and moderately severe or severe dysphagia was significantly
more prevalent among patients with BE compared to patients
with NERD (P=0.013, both Fisher’s exact test).
Hiatal Hernia
Hiatal hernia was present in 107 (66.9%) of the 160
patients. As shown in Table 3, hernia was significantly
more prevalent in patients with either severe ERD or BE
compared to those with either mild ERD or NERD.
Stationary Manometry
Patients with either BE or severe ERD had significantly lower
LES resting pressures than patients with NERD or mild ERD
(Table 3). Similarly, a hypotensive LES was more frequently
found in patients with BE (30/44 patients (68.2%)) compared
to patients with either NERD (14/39 (35.9%), P=0.005) or
mild ERD (16/42 (38.1%), P=0.009, both Mann–Whitney
U test). As for BE, most (19/35 (54.3%)) patients with severe
ERD also had a hypotensive LES.
Regardless of group, most patients had a mechanically
defective LESwith one ormore of the factors hypotensive LES,
short total LES length, or short intra-abdominal LES length
being present. A mechanically defective LES was present in a
higher proportion of patients with severe ERD or BE patients
(80.0% and 77.3%, respectively) compared to patients with
NERD or mild ERD (56.4% and 59.5%, respectively, P=0.046
for NERD versus severe ERD, Mann–Whitney U test).
Distal Esophageal pH and Bilirubin Exposure
As required for study entry, all patients had GERD, defined
by abnormally high distal esophageal acid exposure on
ambulatory pH monitoring. Distal esophageal acid expo-
sure, measured as the total percent time the pH was less
than 4 during the study period, was significantly higher in
patients with either severe ERD or BE compared to patients
with either NERD or mild ERD (see Table 3). Furthermore,
all other measures of acid reflux (upright % time, supine %
time, number of reflux episodes, number of reflux episodes
longer than 5 min, duration of longest reflux episode, and
composite (DeMeester) score) were significantly more
abnormal in patients with BE compared to patients with
either NERD or mild ERD (data not shown). Five acid
reflux measures were also more severe in the BE group
compared to the severe ERD group, with only the number
of reflux episodes and duration of longest episode not
significantly different (data not shown). Four of the seven
acid reflux measures were also significantly more abnormal
in patients with severe ERD compared to NERD patients
(data not shown). Only the supine percent time was
significantly different in the NERD and mild ERD groups,
being higher in the mild ERD group (data not shown).
As shown in Table 3, there was a progressive increase in
median DeMeester score with increasing mucosal injury,
from NERD to mild ERD, severe ERD, and BE. The score
was significantly different between all groups except the
NERD and mild ERD groups and in five of the six
comparisons shown in Table 3. The total percent time was
significantly different in four of the six comparisons
(Table 3). These results, although prespecified, have not
Table 1 Demographic Factors
GERD stage NERD Mild ERD Severe ERD Barrett’s esophagus Total
Number of patients 39 42 35 44 160
Male (%) 25 (64) 28 (67) 23 (66) 35 (79) 111 (69)
Agea 49 (22) 48.5 (19.5) 48 (13) 47.5 (12.5) 48 (15.75)
Duration of follow-up in monthsa 25 (21) 25.5 (18.2) 24 (45) 55 (34.7)b 30 (37)
a Values for age and duration of follow-up are median and (interquartile range)
b Duration of follow-up was significantly longer for patients with Barrett’s esophagus compared to other groups (Barrett’s versus NERD patients P
=0.001, Barrett’s versus mild ERD P<0.001, Barrett’s versus severe ERD P=0.029, all Mann–Whitney test). There were no other significant
demographic differences between the patient groups
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been adjusted to take into account multiple comparisons
and therefore need to be validated in further studies.
Bilirubin exposure was measured in 92 (56.8%) patients.
Bile reflux, as measured by the percentage of time that
absorbance at the wavelength of bilirubin was above the 0.2
threshold, was significantly higher in patients with BE
(median 13.1, interquartile range 20.3) than in patients with
either mild ERD (median 0.3 (14.3)) or severe ERD (2.8
(18.7), P=0.013 and 0.021, respectively, Mann–Whitney
test). Abnormally high esophageal bile exposure was present
in a considerably higher proportion of BE patients (23/29
patients (79.3%)) compared to the other groups of patients
(NERD 10/19 patients (52.6%), mild ERD 10/22 patients
(45.5%), severe ERD 10/20 patients (50%)), but this
difference was significant only for the comparison of BE
versus mild ERD patients (P=0.018, Fisher’s exact test).
Postoperative Evaluation
The postoperative results are shown in Table 4. There were
no significant differences in the prevalence of any of the
symptoms heartburn, regurgitation, or dysphagia among
any groups.
Discussion
This study documents the clinical presentation, pathophysio-
logic features, and response to surgical therapy in patients at
different stages of the spectrum of gastroesophageal reflux
disease. We included only patients with abnormal distal
esophageal acid exposure shown on ambulatory pH monitor-
ing, thus reducing the risk of studying patients whose
symptoms were not reflux-related. The patients were classi-
fied using their index endoscopy report and antireflux
medication history. Patients who received acid suppressant
medication therapy prior to index endoscopy showing NERD
were excluded because of the effect of these medications in
healing erosive disease and the consequent inability to
distinguish whether these patients had NERD or healed ERD.
We believe that this study includes patients with true
NERD who had not received antireflux medications prior to
Table 3 Preoperative Hiatal Hernia, LES Pressure, and Esophageal Acid Exposure
GERD
stage






























8.4 (8.8) 7 (7.1) 5.5 (4.2) 5.2 (5.3) 6.2 (6.15) 0.667 0.004 0.005 0.02 0.025 0.78
Total % time
pH<4b
7.4 (3.33) 7.1 (5.2) 9.0 (5.6) 13.0 (12.4) 8.7 (6.6) 0.698 0.026 <0.001 0.12 <0.001 0.005
DeMeester scoreb 24.8 (13.83) 27.9 (21.5) 36.3 (26.4) 50.6 (52.1) 33 (27.73) 0.395 0.002 <0.001 0.031 <0.001 0.035
a Data shown as number of patients with (percentage). P values calculated using Fisher’s exact test
b Data shown as median with (interquartile range). P values calculated using Mann–Whitney U test
Table 2 Preoperative Symptoms
GERD stage NERD Mild ERD Severe ERD Barrett’s esophagus Total
Heartburn
None or mild 3 (7.7%) 4 (9.5%) 4 (11.4%) 2 (4.5%) 13 (8.1%)
Moderate or severe 36 (92.3%) 38 (90.5%) 31 (88.6%) 42 (95.5%) 147 (91.9%)
Regurgitation
None or mild 14 (35.9%) 18 (42.9%) 7 (20.0%) 11 (25.0%) 50 (31.3%)
Moderate or severe 25 (64.1%) 24 (57.1%) 28 (80.0%) 33 (75.0%) 110 (68.8%)
Dysphagia
None or mild 36 (92.3) 36 (85.7%) 26 (74.3%) 31 (70.5%) 129 (80.6%)
Moderate or severe 3 (7.7%) 6 (14.3) 9 (25.7%) 13 (29.5%) 31 (19.4%)
Data shown are numbers of patients with (percentage)
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endoscopy at USC. The availability of these patients in a
surgery study reflects the probably unusual referral basis of
the USC Foregut Surgery Division in that our patient base
includes some patients with reflux symptoms who are
referred by their family physician directly to this unit rather
than through a gastroenterologist. All patients were con-
tacted, increasing our confidence in their classification, but
we acknowledge it is not possible to be certain about the
pre-endoscopy medication use of all patients because
patients have an imperfect recall of their medication history
and the referral correspondence can be incomplete. Simi-
larly, we acknowledge in this retrospective study that the
patients with persistent esophagitis despite medical therapy
may have received an inadequate dosage or not been fully
compliant, although the significant anatomical and physio-
logical differences between the “healed esophagitis” and
“persistent esophagitis” patient groups (Fig. 1) indicate that
these groups differ in the mechanical properties of their
antireflux barrier rather than merely in the dose of
antireflux medication received.
An important finding of our study was that the
preoperative mechanical factors hiatus hernia, LES resting
pressure, and LES lengths were significantly more impaired
in patients with severe ERD and BE compared to those with
mild ERD and NERD. Esophageal acid and bile reflux also
tended to be worse in the more severe GERD categories. It
is well recognized that hiatal hernia is present in most
patients with BE, and a lower frequency of hernia in
patients with NERD has been reported.4,24,25 In a large case
control study, the presence and size of hernia was strongly
associated with risk of developing high grade dysplasia or
adenocarcinoma in patients with BE.26 Hiatal hernia has
also be identified as an important factor for the develop-
ment of ERD in patients with NERD. In a longitudinal
study of 47 patients with NERD who underwent annual
endoscopy for 5 years, hiatal hernia was a highly significant
risk factor for the development of ERD.27
Our study provides further support for the importance of
the length as well as the resting pressure of the LES in the
etiology of GERD.28 Most of the patients, all of whom had
abnormal esophageal acid exposure, had a mechanically
defective LES because of either a low resting pressure or a
short total or intra-abdominal LES length. The LES tended
to be more frequently and more severely defective, with
significantly lower LES pressures in particular, in patients
with severe ERD or BE compared to those with mild ERD
or NERD. As with hiatal hernia, similarly good outcomes
are provided by fundoplication regardless of GERD
category because the operation recreates a mechanically
competent high pressure zone.
Our findings suggest that the endoscopic extent of
mucosal injury reflects, and is likely to result from, the
extent of mechanical abnormality at the gastroesophageal
barrier and the consequent severity of gastroesophageal
Table 4 Postoperative Symptoms
GERD Stage NERD Mild ERD Severe ERD Barrett’s esophagus Total
Heartburn
None or mild 36 (92.3%) 40 (95.2%) 35 (100%) 42 (95.5%) 153 (95.6%)
Moderate or severe 3 (7.7%) 2 (4.8%) 0 (0%) 2 (4.5%) 7 (4.4%)
Regurgitation
None or mild 39 (100%) 41 (97.6%) 34 (97.1%) 42 (95.5%) 156 (97.5%)
Moderate or severe 0 (0%) 1 (2.4%) 1 (2.9%) 2 (4.5%) 4 (2.5%)
Dysphagia
None or mild 38 (97.4%) 41 (97.6%) 35 (100%) 42 (95.5%) 156 (97.5%)
Moderate or severe 1 (2.6%) 1 (2.4%) 0 (0%) 2 (4.5%) 4 (2.5%)
Data shown are numbers of patients with (percentage)
Preoperative factors:
Hiatal hernia N.S.                           <0.001               N.S.     
LES pressure N.S. 0.02 N.S.
DeMeester score N.S. 0.03                              0.03  
NERD   Mild esophagitis Severe esophagitis Barrett’s esophagus
Postoperative factors:
No/mild symptoms                             N.S.               N.S. N.S. 
Figure 1 The numbers shown are P values for selected preoperative factors and postoperative outcome comparing NERD versus mild ERD, mild
versus severe ERD, and severe ERD versus BE. N.S. not significant.
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reflux. Furthermore, they suggest that progression to severe
GERD usually requires the development of a hiatal hernia
and a defective LES. This hypothesis is supported by a
study from Northwestern University in which regression
analysis was used to model the major risk factors for ERD
in patients with symptomatic GERD. Similar to our
findings, the authors reported that hiatal hernia size and
LES pressure are the dominant determinants of esophagitis
presence and severity.29
Several studies have found similar quality of life and
symptom severity scores for patients with ERD and
NERD.4,24,30,31 Consistent with this, the symptom presen-
tation for patients with NERD was not significantly
different to that for patients with ERD in this study. The
severity of reflux symptoms in patients with NERD
indicates that these patients have significant illness and
the same need for effective treatment as patients with ERD
or BE. Patients with severe ERD or BE tended to have
more severe regurgitation and dysphagia, which corre-
sponds with the worse reflux and higher prevalence of
hernia in these groups. A high prevalence of dysphagia
among patients with BE has been noted previously.32
As expected, patients with BE had the most severe
gastroesophageal reflux. All measures of acid reflux were
significantly more abnormal in patients with BE compared
to either NERD or mild ERD patients. Patients with NERD
tended to have less severe reflux than patients with ERD,
especially those with severe ERD. This correlates with the
observation that the severity of esophagitis correlates with
amount of acid exposure33 and similar findings have been
reported by others.25 The composite (DeMeester) score,
which includes all the acid reflux measures in a weighted
calculation of reflux severity, discriminated most clearly
between the different GERD stages in this and a similar
study.34
We have presented the findings without applying a
correction for multiple comparisons; thus, one explanation
is that they are false positive results due to chance alone.
However, we observed consistent positive findings for
different variables that are known to share an association
(e.g., hernia and pH exposure), reducing the likelihood of
this explanation. Furthermore, the findings are consistent
with those expected from the large number of previous
studies that have examined the influence of mechanical
factors in the etiology of GERD. Even if the most
conservative (Bonferroni) correction is applied to take into
account the multiple (20 comparisons, corrected P<0.0025)
analyses performed in the analysis with the largest number
of comparisons (Table 3), although fewer findings would be
classified as statistically significant, the same principal
conclusions apply.
All patients underwent a circumferential (Nissen) lapa-
roscopic fundoplication and they were all contacted for this
study at least 1 year after operation. We found similarly
excellent symptom control in all patient groups, with no
significant differences in outcome according to the stage of
GERD. In contrast, consistently and significantly worse
outcomes are reported for medical treatment for NERD
compared to erosive disease.16–18 Lind et al., for example,
documented complete symptom resolution in only 46% of
NERD patients using 20 mg omeprazole daily for 4 weeks,
and satisfaction with therapy was reported by only two
thirds of patients.35 In a pooled data study of 2,458 patients
who received differing but standard PPI doses, complete
heartburn resolution was achieved in only 63% of patients
at the end of 4 weeks’ treatment.36
The results for surgery for patients with NERD in this
and other surgery studies15,34,37 are far superior to those for
medical PPI therapy. In a study of 89 patients with NERD
who underwent laparoscopic Nissen fundoplication, the
improvement in quality of life, as measured using the
Gastrointestinal Quality of Life Index tool, was significant-
ly greater in those with NERD compared to patients with
erosive esophagitis because quality of life was more
impaired preoperatively in the NERD group.37 At 5 years
after surgery, quality of life in both NERD and ERD patient
groups was comparable to healthy controls.37
The favorable results for surgical therapy in these and the
current study may be partly explained by the fact that the
patients without erosive esophagitis all had pH study proven
reflux disease.15,34,37 We and others have previously reported
better postfundoplication outcomes in patients with abnormal
distal esophageal acid exposure compared to patients with
normal pH study results,38,39 and the surgeon should be wary
of operating on patients with no mucosal injury and acid
reflux within the normal range. These patients are diagnosed
with GERD by correlating symptoms with reflux events
(positive symptom index)40 or by demonstrating relief of
symptoms with a test course of antacid or acid suppressant
therapy. There is evidence that esophageal visceral hyper-
sensitivity, sustained esophageal contractions, and abnormal
tissue resistance41 may be involved in causing symptoms in
patients with minimal acid reflux, but stress,42 psychologi-
cal,43,44 and psychiatric45 illness may also be factors in the
these patients with “functional heartburn” or the “hypersen-
sitive esophagus”.40,46,47
Several studies have shown that NERD, ERD, and BE
are not separate diseases but part of a spectrum of GERD.1,8
As is typical of a spectrum disease, patients can progress
and regress to and from different endoscopic stages. Our
results suggest that, as well as being a spectrum disease,
GERD can also be usefully regarded as a categorical
disease that includes the two categories mild (NERD and
mild ERD) and severe (severe ERD and BE) GERD. In
support of categorizing GERD as mild and severe disease,
the ProGERD study reported that mild erosive esophagitis
608 J Gastrointest Surg (2009) 13:602–610
(Los Angeles classification grade A or B) behaved in a
similar way to NERD.
Conclusions
The spectrum of GERD includes NERD, mild and severe
ERD, and BE. The clinical presentation is similar at different
stages of this spectrum, although patients with severe ERD or
BE may have more severe regurgitation or dysphagia. The
stage of disease correlates well with the mechanical and
anatomic features of the gastroesophageal reflux barrier, with
hiatal hernia and a hypotensive lower esophageal sphincter
significantly more prevalent in patients with severe ERD or
BE. Nissen fundoplication, which reduces the hernia and
augments the lower esophageal high pressure zone, provides
similarly good or excellent results, regardless of the endo-
scopic appearance, in patients with all stages of GERD.
Support None.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
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